Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SMAD5 is an intracellular signal transducer and transcriptional modulator within the transforming growth factor-beta (TGF-β) superfamily signaling pathways, particularly those involving bone morphogenetic proteins (BMPs). It regulates cell proliferation, differentiation, apoptosis, and development—especially important in chondrogenesis, osteogenesis, hematopoiesis inhibition, and embryonic development. It also maintains bioenergetic homeostasis by regulating cytoplasmic metabolic machinery.
SMAD5 acts as an intracellular messenger for BMP signals. Upon BMP ligand binding to their receptors, SMAD5 is phosphorylated by type I BMP receptor kinases. Phosphorylated SMAD5 forms complexes—often with co-SMAD4—and translocates to the nucleus where it regulates target gene expression in cooperation with other transcription factors or co-factors. Non-phosphorylated SMAD5 also has cytoplasmic functions related to energy metabolism, promoting mitochondrial respiration and glycolysis under certain conditions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Smad family member 5 (SMAD5).